Newsroom

LOS ANGELES--(BUSINESS WIRE)--RARE Investors Have Opportunity to Join Ultragenyx Pharmaceutical Inc. Fraud Investigation with the Schall Law Firm...

MUSKEGO, Wis.--(BUSINESS WIRE)--U.S. Representative Scott Fitzgerald (WI-05) joined with the Federal Home Loan Bank of Chicago (FHLBank Chicago) and local leaders today for a discussion of the housing affordability challenges facing communities across Wisconsin. Following a tour of a former Muskego grade school that has been redeveloped into low-cost housing, the roundtable discussion brought together representatives from Associated Bank, the Wisconsin Partnership for Housing Development, Inc....

ATLANTA--(BUSINESS WIRE)--The Coca-Cola Company today announced that Luisa Ortega will become president of the Europe operating unit effective Sept. 1, succeeding Nikos Koumettis, who will retire in 2026 after a 25-year career with the company. Koumettis will remain with the company through Feb. 28, 2026, as a senior advisor. He will also serve on the board of directors of Hindustan Coca-Cola Beverages Pvt. Ltd., a company-owned bottler in India. Ortega joined Coca-Cola in 2019 and currently se...

PARIS--(BUSINESS WIRE)--Regulatory News: Teleperformance SE (Paris:TEP) a procédé à l’acquisition d’actions propres dans le cadre du programme de rachat d’actions tel qu’autorisé par son Assemblée générale du 21 mai 2025. Ces acquisitions ont été effectuées dans le cadre de l’objectif d’annulation. Il est précisé que les informations détaillées par transaction peuvent être consultées sur le site internet de la société au lien suivant : https://www.tp.com/fr-fr/investisseurs/publications-et-even...

PARIS--(BUSINESS WIRE)--Regulatory News: Teleperformance SE (Paris:TEP) purchased certain of its own shares in connection with the share repurchase program as authorized by its Shareholders’ Meeting held on May 21, 2025. These repurchases were carried out in connection with the objective of cancellation. It is specified that the detailed information by transaction is available on the Company’s website at the following link: https://www.tp.com/en-us/investors/publications-and-events/regulated-in...

PALO ALTO, Calif.--(BUSINESS WIRE)--Workato®, the leader in agentic orchestration, unveiled the speaker lineup for World of Workato (WOW) 2025, its flagship customer and partner conference, taking place August 18-20 at The Cosmopolitan in Las Vegas. The company also announced the focus for the conference and its global roadshow stops. With the theme Re(AI)lize Tomorrow, WOW 2025 marks a defining moment for the enterprise AI landscape. This year’s event will unveil how AI agents are no longer hy...

LEMONT, Ill.--(BUSINESS WIRE)--Aurora is revolutionizing how scientists use AI and simulation to tackle some of the most complex challenges in science and engineering....

MARKHAM, Ontario--(BUSINESS WIRE)--Autrefois considérés comme peu dignes de confiance pour les longs voyages, les véhicules électriques comme le VF 8 de VinFast engloutissent maintenant des milliers de kilomètres à travers l'Amérique du Nord, et les conducteurs de l'Ontario à la Floride découvrent le confort, les économies réalisées et une communauté grandissante de voyageurs en VE. Il y a dix ans, suggérer un road trip en véhicule électrique (VE), l’un des passe-temps favoris en Amérique du No...

SALEM, Ore.--(BUSINESS WIRE)--Oregon Bancorp, Inc. (OTCBB: ORBN) (“the Company”), parent company of Willamette Valley Bank, today announced net income of $719,000, or $0.29 per common share, for the second quarter of 2025. This compares to net income of $520,000, or $0.21 per share, for the quarter ended March 31, 2025. The Company’s return on average assets and return on average equity for the second quarter were 0.6% and 3.9%, respectively. Net interest margin improved to 3.7%, compared to 3....

VAŠINGTONAS--(BUSINESS WIRE)--„Nanochon“, Vašingtone, DC, ir Baltimorėje, MD, įsikūrusi ortopedijos prietaisų biotechnologijų bendrovė ir kurianti kelio sąnario kremzlės defektams gydyti skirtus implantus, džiaugiasi galėdama pranešti, kad jai buvo suteiktas „Health Canada“ patvirtinimas dėl pirmojo klinikinio tyrimo su žmonėmis. Tyrimui vadovaus pagrindinis tyrėjas, dr. Fathi Abuzgaya, kuris bendradarbiaus su sporto medicinos specialistais dr. Joel Lobo, dr. Kajeandra Ravichandiran ir dr. Marc...